Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Cancer02:18

Cancer

53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Response to Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.

The Laryngoscope·2026
Same author

Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.

The Laryngoscope·2025
Same author

Evidence-Based Lung Cancer Screening in a Tailored Package.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

NCI Resources for Cancer Immunoprevention Research.

Cancer immunology research·2024
Same author

Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines.

Cancer prevention research (Philadelphia, Pa.)·2023
Same author

Emerging Trends in Cancer Prevention Agent Development.

Journal of cancer prevention·2023
Same journal

Proteomic analysis of sphingolipid metabolic enzymes with risk of bladder cancer incidence and mortality in the Atherosclerosis Risk in Communities (ARIC) Study.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Cancer Screening Adherence in the US by Smoking and Vaping Status, 2023.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Will they use it? Patient and provider acceptance of chatbot screening and counseling for hereditary cancer syndromes in a geographically underserved population.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels.

Cancer prevention research (Philadelphia, Pa.)·2026
See all related articles

Related Experiment Video

Updated: Jan 12, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.1K

Cancer Prevention/Interception Agent Development.

Mark Steven Miller1, Frank G Ondrey2

  • 1CancerTox Consulting, Greensboro, North Carolina.

Cancer Prevention Research (Philadelphia, Pa.)
|November 3, 2025
PubMed
Summary
This summary is machine-generated.

Developing effective cancer preventive agents requires identifying high-risk populations and optimizing drug delivery. Future strategies will combine vaccines with chemo/immunopreventive agents for reduced cancer mortality.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.3K

Related Experiment Videos

Last Updated: Jan 12, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.1K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.3K

Area of Science:

  • Oncology
  • Preventive Medicine
  • Drug Development

Background:

  • Limited clinical use of cancer preventive/interceptive agents despite decades of research.
  • Advances in understanding early-stage cancer and premalignant lesions offer opportunities for improved prevention strategies.

Purpose of the Study:

  • To outline critical considerations for advancing cancer prevention and interception agents.
  • To emphasize the need for improved methodologies in agent development and clinical translation.

Main Methods:

  • Identifying high-risk populations and relevant molecular targets.
  • Utilizing accurate animal models for early-stage human lesions.
  • Evaluating agent physiochemical properties, toxicity, solubility, and organ accumulation.
  • Assessing long-term tolerability in healthy, high-risk individuals.

Main Results:

  • Ensuring agents demonstrate significant tumor development reduction (≥50%) in models.
  • Considering strategies to minimize side effects, such as combination therapy and alternative delivery systems.
  • Highlighting the importance of early industry collaboration for clinical trial progression.

Conclusions:

  • Cancer prevention and interception require a multi-faceted approach, integrating robust preclinical validation with clinical development.
  • Future efforts will likely involve combination therapies, including vaccines and chemo/immunopreventive agents, to enhance efficacy and reduce cancer mortality.